These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6481115)

  • 61. Some observations on the effects of treatment with lactulose on patients with chronic hepatic encephalopathy.
    Zeegen R; Drinkwater JE; Fenton JC; Vince A; Dawson AM
    Q J Med; 1970 Apr; 39(154):245-63. PubMed ID: 5449591
    [No Abstract]   [Full Text] [Related]  

  • 62. [Early neuropsychological changes in patients with nonalcoholic liver cirrhosis].
    Loguercio C; Immirzi MC; Perrone L; Del Vecchio Blanco C; Coltorti M
    Minerva Dietol Gastroenterol; 1990; 36(4):227-33. PubMed ID: 2089288
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cirrhosis, hyperammonemia and Lactulose.
    Rottiers R; Van Egmond J; Verbruggen R; Dierick G; Vermeulen A; Standaert L; De Groote J; Demeulenaere L
    Tijdschr Gastroenterol; 1968; 11(2):123-39. PubMed ID: 5679042
    [No Abstract]   [Full Text] [Related]  

  • 64. [Confusion and abnormal liver enzyme levels: problems with diagnosing hepatic encephalopathy].
    Hendriks ME; van Westerloo DJ; Portegies P
    Ned Tijdschr Geneeskd; 2007 Dec; 151(49):2701-6. PubMed ID: 18225787
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy.
    Kale RA; Gupta RK; Saraswat VA; Hasan KM; Trivedi R; Mishra AM; Ranjan P; Pandey CM; Narayana PA
    Hepatology; 2006 Apr; 43(4):698-706. PubMed ID: 16557540
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison between neomycin and lactulose in 173 patients with hepatic encephalopathy: a randomized clinical study.
    Orlandi F; Freddara U; Candelaresi MT; Morettini A; Corazza GR; Di Simone A; Dobrilla G; Cavallini G
    Dig Dis Sci; 1981 Jun; 26(6):498-506. PubMed ID: 7016484
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Blood mercaptan and ammonia concentrations in cirrhotics after a protein load.
    Kromhout J; McClain CJ; Zieve L; Doizaki WM; Gilberstadt S
    Am J Gastroenterol; 1980 Dec; 74(6):507-11. PubMed ID: 7211813
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of lactitol on blood ammonia response to oral glutamine challenge in cirrhotic patients: evidence for an effect of nonabsorbable disaccharides on small intestine ammonia generation.
    Masini A; Efrati C; Merli M; Attili AF; Amodio P; Ceccanti M; Riggio O
    Am J Gastroenterol; 1999 Nov; 94(11):3323-7. PubMed ID: 10566738
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Propranolol and the risk of hepatic encephalopathy in liver cirrhosis].
    Calès P
    Ann Gastroenterol Hepatol (Paris); 1989 Dec; 25(7):315-7. PubMed ID: 2610483
    [No Abstract]   [Full Text] [Related]  

  • 70. Lactulose: a drug in search of a modus operandi.
    Conn HO
    Gastroenterology; 1978 Mar; 74(3):624-6. PubMed ID: 24572
    [No Abstract]   [Full Text] [Related]  

  • 71. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage.
    Keshavarzian A; Holmes EW; Patel M; Iber F; Fields JZ; Pethkar S
    Am J Gastroenterol; 1999 Jan; 94(1):200-7. PubMed ID: 9934756
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prospective randomized crossover trial comparing fibre with lactulose in the treatment of idiopathic chronic constipation.
    Quah HM; Ooi BS; Seow-Choen F; Sng KK; Ho KS
    Tech Coloproctol; 2006 Jul; 10(2):111-4. PubMed ID: 16773290
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Oral glutamine challenge in cirrhotics pre- and post-liver transplantation: a psychometric and analyzed EEG study.
    Oppong KN; Al-Mardini H; Thick M; Record CO
    Hepatology; 1997 Oct; 26(4):870-6. PubMed ID: 9328307
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lactulose in the treatment of chronic hepatic encephalopathy: report of three cases.
    Juttijudata P; Meensook C
    J Med Assoc Thai; 1981 Dec; 64(12):636-9. PubMed ID: 6153032
    [No Abstract]   [Full Text] [Related]  

  • 75. Hepatic encephalopathy: pathophysiology and advances in therapy.
    Av SP
    Trop Gastroenterol; 2007; 28(1):4-10. PubMed ID: 17896602
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lactulose in the treatment of acute and chronic hepatic encephalopathy.
    Fung WP; Khoo OT
    Singapore Med J; 1971 Jun; 12(3):176-80. PubMed ID: 5094427
    [No Abstract]   [Full Text] [Related]  

  • 77. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Possible therapeutic uses of lactulose other than in porto-systemic encephalopathy].
    Alvaro D; Angelico M; Attili AF
    Minerva Dietol Gastroenterol; 1986; 32(1):67-72. PubMed ID: 3703321
    [No Abstract]   [Full Text] [Related]  

  • 79. [Lactulose and its derivatives--treatment of hepatic encephalopathy and other possible indications for its use].
    Fehér J; Prónai L
    Orv Hetil; 1993 Jun; 134(26):1417-9. PubMed ID: 8332363
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Treatment of healthy salmonella carriers with lactulose beta-galactosido-fructose (author's transl)].
    Hoffmann K
    Dtsch Med Wochenschr; 1975 Jun; 100(26):1429-31. PubMed ID: 238823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.